Innate biosignature of treatment failure in human cutaneous leishmaniasis
Abstract The quality and magnitude of the immune and inflammatory responses determine the clinical outcome of Leishmania infection, and contribute to the efficacy of antileishmanial treatments. However, the precise immune mechanisms involved in healing or in the chronic immunopathology of human cuta...
Saved in:
| Main Authors: | María Adelaida Gómez, Ashton Trey Belew, Deninson Alejandro Vargas, Lina Giraldo-Parra, Neal Alexander, David E. Rebellón-Sánchez, Theresa A. Alexander, Najib M. El-Sayed |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-58330-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adaptation and performance of a mobile application for early detection of cutaneous leishmaniasis.
by: Luisa Rubiano, et al.
Published: (2021-02-01) -
Alternative Methylated Biosignatures. I. Methyl Bromide, a Capstone Biosignature
by: Michaela Leung, et al.
Published: (2022-01-01) -
Unusual Presentation of Cutaneous Leishmaniasis: Ocular Leishmaniasis
by: Masoud Doroodgar, et al.
Published: (2017-01-01) -
Cutaneous leishmaniasis in Iraq
by: Abdulghani Mohamad AlSamarai, et al.
Published: (2009-03-01) -
Cutaneous Leishmaniasis: Revisited
by: Saraswoti Neupane
Published: (2018-03-01)